EPW confirmed that it would meet 2016 guidance and also provided 2017 outlook which didn't look bad. Why is the sell off?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025